Serum Cystatin C Reflects Angiographic Coronary Collateralization in Stable Coronary Artery Disease Patients with Chronic Total Occlusion.

PubWeight™: 0.88‹?›

🔗 View Article (PMC 4581619)

Published in PLoS One on September 24, 2015

Authors

Ying Shen1, Feng Hua Ding1, Rui Yan Zhang1, Qi Zhang1, Lin Lu2, Wei Feng Shen2

Author Affiliations

1: Department of Cardiology, Rui Jin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, People's Republic of China.
2: Department of Cardiology, Rui Jin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, People's Republic of China; Institute of Cardiovascular Diseases, Shanghai Jiaotong University School of Medicine, Shanghai 200025, People's Republic of China.

Associated clinical trials:

Adavanced Glycated Endproducts and Development of CAD (AGENDA) | NCT02089360

Articles cited by this

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA (2001) 118.65

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med (2008) 57.29

Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care (2003) 20.07

2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2013) 18.17

Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol (2006) 8.05

Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol (1985) 4.61

Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation (1990) 3.49

Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation (1999) 3.16

2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol (2007) 2.95

Collateral circulation: past and present. Basic Res Cardiol (2008) 2.60

The impact of the coronary collateral circulation on mortality: a meta-analysis. Eur Heart J (2011) 2.33

Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis (2005) 2.17

Mildly decreased glomerular filtration rate is associated with poor coronary collateral circulation in patients with coronary artery disease. Clin Cardiol (2011) 2.08

Predictors of poor coronary collateral development in patients with stable coronary artery disease: neutrophil-to-lymphocyte ratio and platelets. Anatol J Cardiol (2014) 2.04

Pathways and functional significance of the coronary collateral circulation. Circulation (1974) 1.72

Cystatin C and cardiovascular risk. Clin Chem (2009) 1.57

Relationship between plasma apelin level and coronary collateral circulation. Atherosclerosis (2014) 1.45

Assessment of the human coronary collateral circulation. Circulation (2010) 1.33

The human coronary collateral circulation: development and clinical importance. Eur Heart J (2013) 1.23

Cathepsin L is significantly associated with apoptosis and plaque destabilization in human atherosclerosis. Atherosclerosis (2008) 1.13

Cystatin C: an emerging biomarker in cardiovascular disease. Curr Top Med Chem (2013) 1.03

Plasma cathepsin S and cystatin C levels and risk of abdominal aortic aneurysm: a randomized population-based study. PLoS One (2012) 0.99

Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion. Cardiovasc Diabetol (2013) 0.94

Plasma chemokine levels are associated with the presence and extent of angiographic coronary collaterals in chronic ischemic heart disease. PLoS One (2011) 0.89

A uremic solute, P-cresol, inhibits the proliferation of endothelial progenitor cells via the p38 pathway. Circ J (2011) 0.89

Clinical parameters associated with collateral development in patients with chronic total coronary occlusion. Heart (2013) 0.88

Why is coronary collateral growth impaired in type II diabetes and the metabolic syndrome? Vascul Pharmacol (2012) 0.87

Cystatin C: a strong marker for lower limb ischemia in Chinese type 2 diabetic patients? PLoS One (2013) 0.86

Prognostic value of cystatin C in acute coronary syndromes: enhancer of atherosclerosis and promising therapeutic target. Clin Chem Lab Med (2011) 0.85

Increased serum level of CTRP1 is associated with low coronary collateralization in stable angina patients with chronic total occlusion. Int J Cardiol (2014) 0.85

Multicenter study of creatinine- and/or cystatin C-based equations for estimation of glomerular filtration rates in Chinese patients with chronic kidney disease. PLoS One (2013) 0.85

Relation of C-reactive protein to coronary collaterals in patients with stable angina pectoris and coronary artery disease. Am J Cardiol (2006) 0.84

Relation between serum monocyte chemoattractant protein-1 and coronary collateral development. Coron Artery Dis (2010) 0.84

Predictor of poor coronary collaterals in chronic kidney disease population with significant coronary artery disease. BMC Nephrol (2012) 0.84

Poor coronary collateral vessel development in patients with mild to moderate renal insufficiency. Clin Res Cardiol (2010) 0.83

Plasma cathepsin L and its related pro/antiangiogenic factors play useful roles in predicting rich coronary collaterals in patients with coronary heart disease. J Int Med Res (2010) 0.82

The relationship of chronic angiotensin converting enzyme inhibitor use and coronary collateral vessel development. Int Heart J (2007) 0.80

Association between the dosage and duration of statin treatment with coronary collateral development. Coron Artery Dis (2006) 0.80

Clinical and angiographic features associated with coronary collateralization in stable angina patients with chronic total occlusion. J Zhejiang Univ Sci B (2013) 0.79

Poor coronary collateral circulation is associated with higher concentrations of soluble adhesion molecules in patients with single-vessel disease. Coron Artery Dis (2004) 0.79

Protease-activated receptor (PAR)2, but not PAR1, is involved in collateral formation and anti-inflammatory monocyte polarization in a mouse hind limb ischemia model. PLoS One (2013) 0.78

Tumour necrosis factor alpha concentration and collateral flow in patients with coronary artery disease and normal systolic left ventricular function. Heart (2003) 0.77

Coronary collateral circulation in patients of coronary ectasia with significant coronary artery disease. PLoS One (2014) 0.77

Clinical relevance of angiographic coronary collaterals during primary coronary intervention for acute ST-elevation myocardial infarction. Chin Med J (Engl) (2014) 0.76

Association of blood pressure and coronary collateralization in type 2 diabetic and nondiabetic patients with stable angina and chronic total occlusion. J Hypertens (2015) 0.76

The prognostic significance of coronary collaterals in patients with ischemic heart disease: an essential response to ischemia. Int J Cardiol (2008) 0.76